Trial Profile
Effects of ezetimibe on postprandial hyperlipidaemia and hyperglycemia in Japanese hyperlipidemic patients; Double-blinded crossover randomized clinical trial.
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 01 Jul 2011
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary)
- Indications Hyperlipidaemia
- Focus Pharmacodynamics
- 28 Jun 2011 Results presented at the 71st Annual Scientific Sessions of the American Diabetes Association.
- 22 Dec 2010 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan ecord.
- 13 Jan 2010 New trial record